PHARINGOTRICIN * 20CPR GOLD 2,5MG

PHARINGOTRICIN * 20CPR GOLD 2,5MG

Therapeutic indications

Topical therapy of stomatitis of bacterial origin.

Dosage and method of use

Posology Let 1 tablet dissolve slowly in the mouth every ½ - 1 hour. Continue the treatment for two or more days. Do not exceed the daily dosage of 10 tablets.

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Side effects

Since thyrotricin is poorly absorbed by the mucous membranes, the chances of allergic reactions are reduced. Rarely, blackening of the tongue, glossitis, sensitization reactions may occur. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: www.agenziafarmaco.gov.it/it/responsabili.

Special warnings

The use, especially if prolonged, of the product can give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and institute an adequate therapy: similar treatment must be observed in the event of the development of infections from non-sensitive germs. Pediatric population In very early childhood, the product should be administered in cases of real need, under the direct supervision of the doctor. PHARINGOTRICIN contains glucose, lactose and sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine.

Pregnancy and breastfeeding

In pregnant and lactating women, the product should be administered in cases of real need, under direct medical supervision.

Expiration and retention

This medicine does not require any special storage conditions.

Interactions with other drugs

There are no known interactions with other medicines.

Overdose

There are no known overdose phenomena as the poor absorption of thyrotricin through the mucous membranes reduces the possibility of toxic phenomena at the recommended doses.

Active principles

One orodispersible tablet contains: 2.5 mg thyrotricin. Excipients with known effects: glucose 20 mg, lactose 275 mg and sucrose 467 mg. For the full list of excipients, see section 6.1.

Excipients

Menthol - Corn starch - Gum arabic - Glucose - Lactose - Magnesium stearate - Sucrose.